Drugs used for Status epilepticus not listed below:
- Oromucosal solution 5mg/ml prefilled oral syringe 2.5mg, 5mg, 7.5mg, 10mg (£22.88 = 10mg prefilled oral syringe)
- >6 months to <1 year: 2.5mg
- 1 year to <5 years: 5mg
- 5 years to <10 years: 7.5mg
- 10 years to <18 years: 10mg
- 18 years and older: 10mg (unlicensed)
- Prescribe by brand (the brand of midazolam should be specified on the individual patient care plan). Buccolam® brand is recommended for new initiations
- Prescribers are reminded that the different brands of buccal midazolam contain different concentrations of the drug
- For patients currently established on Epistatus® brand (10mg/ml, non-formulary), continued prescribing is accepted
- The brand should not be changed without the full involvement of specialist and patient/carer
- For infants between 3-6 months of age treatment should be in a hospital setting where monitoring is possible and resuscitation equipment is available
- Whilst Buccolam is not licensed for patients aged 18 years and older, NICE CG137 recommends buccal midazolam as first-line treatment for prolonged or repeated seizures in adults in the community. Rectal diazepam (licensed) may be used if preferred, or if midazolam is not available
- Patients should have an individual care plan which should clearly define when administration is necessary; family/carers should be trained in administration
- Injection 1mg/ml, 2ml, 5ml ampoule
- Infusion 1mg/ml, 50ml vial
- Injection 5mg/ml, 2ml ampoule
- There have been reports of overdose when high strength midazolam has been used for conscious sedation. Use should be restricted to general anaesthesia, intensive care, palliative care or other situations where the risk has been assessed.
- Flumazenil must be kept in all departments that use IV or SC midazolam (NPSA/2008/RRR011).
- Midazolam is a Schedule 3 CD and must be ordered in the CD order book.
- Tablets 1mg (£4.41 = 1mg daily)
- Injection 4mg in 1ml
- Intravenous injection (into large vein) 2mg/ml (for use in Plymouth Hospitals NHS Trust)
- Oral, anxiety, 1–4mg daily in divided doses; elderly (or debilitated) half adult dose
- Insomnia associated with anxiety, 1–2mg at bedtime
- I/M (when oral and intravenous routes not possible) or slow I/V injection (into a large vein), acute panic attacks, 25–30 micrograms/kg (usual range 1.5–2.5mg), repeated every 6 hours if necessary
- Status eplileticus: by slow I/V (into large vein), 4mg repeated once after 10 minutes if necessary; child under 12 years 100 micrograms/kg (maximum 4mg) repeated once after 10 minutes if necessary
- Lorazepam has a short duration of action and is used for the management of the acutely disturbed patients in accordance with the appropriate Trust's rapid tranquillisation guidelines.
- Injection powder for reconstitution, 500mg vial
- Rectally administered 5mL ampoule. Paediatrics only.
- Enema 50% in olive oil 30ml (unlicensed) (for use in Plymouth Hospitals NHS Trust)
4. Central Nervous System >
4.8 Antiepileptic drugs >
4.8.2 Drugs used in status epilepticus
- First line
- Second line